---
figid: PMC8013908__PATH-9999-0-g001
figlink: pmc/articles/PMC8013908/figure/path5642-fig-0001/
number: F1
caption: SARS‐CoV‐2 entry and immune activation. SARS‐CoV‐2 needs to bind to ACE2
  to enter the cell, either by TMPRSS2‐dependent direct fusion of the viral envelope
  to the cell membrane or by TMPRSS2‐enhanced endocytosis. Furin and NRP1 can also
  facilitate viral entry. Viral escape by fusion to the endosomal membrane is CTSL‐dependent,
  as is activation of TLR7, which is essential in the recognition of single‐stranded
  RNA viruses and induction of type I IFN via IRF7. Activation of RAS by viral infection,
  via Ang II and AT1R, induces the TLR4/MyD88/NFκB pathway to increase pro‐inflammatory
  cytokines IL‐1β, IL‐6, IL‐8, and TNF‐α. After DJ‐1‐induced endocytosis of TLR4,
  type I IFN, antiviral kinases, and the anti‐inflammatory cytokine IL‐10 are activated.
  Nsp3 and ‐6 of SARS‐CoV‐2 inhibit IFN activation via the IRF3 pathway. Nsp5 blocks
  HDAC2, preventing it from decreasing IL‐8, a pro‐inflammatory cytokine with a role
  in NET formation. MAS is stimulated by the pro‐inflammatory TLR4/MyD88‐dependent
  pathway and inhibited by the anti‐inflammatory cytokine IL‐10. ACE2, angiotensin‐converting
  enzyme 2; Ang II, angiotensin II; AT1R, angiotensin II type 1 receptor; CTSL, cathepsin
  L; HDAC2, histone deacetylase 2; IL, interleukin‐1β/6/8/10; IRAK1/4, interleukin
  1 receptor associated kinase 1/4; IRF3/7, interferon regulatory factor 3/7; MAS,
  macrophage activation syndrome; MyD88, myeloid differentiation primary response
  88; NET, neutrophil extracellular trap; NFκB, nuclear factor kappa B; NRP1, neuropilin
  1; Nsp3/5/6, nonstructural protein 3/5/6; ORF3b/6, open reading frame 3b/6; P, phosphate;
  PKR, double‐stranded (ds)RNA‐dependent protein kinase; RAS, renin–angiotensin system;
  RdRp, RNA‐dependent RNA polymerase; TBK1, TANK binding kinase 1; TLR, toll‐like
  receptor 3/4/7; TMPRSS2, transmembrane serine protease 2; TNFα, tumour necrosis
  factor α; TRAF6, tumour necrosis factor receptor‐associated factor 6; TRAM, TRIF‐related
  adaptor molecule; TRIF, Toll‐IL‐1 receptor domain‐containing adaptor inducing IFN‐β;
  type I IFN, type I interferon.
pmcid: PMC8013908
papertitle: 'COVID‐19: immunopathology, pathophysiological mechanisms, and treatment
  options.'
reftext: Larissa E van Eijk, et al. J Pathol. 2021 Mar 25 :10.1002/path.5642.
pmc_ranked_result_index: '78750'
pathway_score: 0.9161687
filename: PATH-9999-0-g001.jpg
figtitle: SARS‐CoV‐2 entry and immune activation
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8013908__PATH-9999-0-g001.html
  '@type': Dataset
  description: SARS‐CoV‐2 entry and immune activation. SARS‐CoV‐2 needs to bind to
    ACE2 to enter the cell, either by TMPRSS2‐dependent direct fusion of the viral
    envelope to the cell membrane or by TMPRSS2‐enhanced endocytosis. Furin and NRP1
    can also facilitate viral entry. Viral escape by fusion to the endosomal membrane
    is CTSL‐dependent, as is activation of TLR7, which is essential in the recognition
    of single‐stranded RNA viruses and induction of type I IFN via IRF7. Activation
    of RAS by viral infection, via Ang II and AT1R, induces the TLR4/MyD88/NFκB pathway
    to increase pro‐inflammatory cytokines IL‐1β, IL‐6, IL‐8, and TNF‐α. After DJ‐1‐induced
    endocytosis of TLR4, type I IFN, antiviral kinases, and the anti‐inflammatory
    cytokine IL‐10 are activated. Nsp3 and ‐6 of SARS‐CoV‐2 inhibit IFN activation
    via the IRF3 pathway. Nsp5 blocks HDAC2, preventing it from decreasing IL‐8, a
    pro‐inflammatory cytokine with a role in NET formation. MAS is stimulated by the
    pro‐inflammatory TLR4/MyD88‐dependent pathway and inhibited by the anti‐inflammatory
    cytokine IL‐10. ACE2, angiotensin‐converting enzyme 2; Ang II, angiotensin II;
    AT1R, angiotensin II type 1 receptor; CTSL, cathepsin L; HDAC2, histone deacetylase
    2; IL, interleukin‐1β/6/8/10; IRAK1/4, interleukin 1 receptor associated kinase
    1/4; IRF3/7, interferon regulatory factor 3/7; MAS, macrophage activation syndrome;
    MyD88, myeloid differentiation primary response 88; NET, neutrophil extracellular
    trap; NFκB, nuclear factor kappa B; NRP1, neuropilin 1; Nsp3/5/6, nonstructural
    protein 3/5/6; ORF3b/6, open reading frame 3b/6; P, phosphate; PKR, double‐stranded
    (ds)RNA‐dependent protein kinase; RAS, renin–angiotensin system; RdRp, RNA‐dependent
    RNA polymerase; TBK1, TANK binding kinase 1; TLR, toll‐like receptor 3/4/7; TMPRSS2,
    transmembrane serine protease 2; TNFα, tumour necrosis factor α; TRAF6, tumour
    necrosis factor receptor‐associated factor 6; TRAM, TRIF‐related adaptor molecule;
    TRIF, Toll‐IL‐1 receptor domain‐containing adaptor inducing IFN‐β; type I IFN,
    type I interferon.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HRAS
  - KRAS
  - NRAS
  - CXCL8
  - NRP1
  - TLR4
  - MYD88
  - IRAK4
  - IRAK1
  - TRAF6
  - TMPRSS2
  - FURIN
  - ACE2
  - CTSL
  - TLR7
  - TLR3
  - TRAF3
  - TBK1
  - IRF7
  - IRF3
  - SH2D3C
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - IFNA1
  - SGCG
  - IL1B
  - HDAC2
  - CoV-2
  - SARS-CoV-2
genes:
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: IL-8
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: NRP1
  symbol: NRP1
  source: hgnc_symbol
  hgnc_symbol: NRP1
  entrez: '8829'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: MyD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: IRAK4
  symbol: IRAK4
  source: hgnc_symbol
  hgnc_symbol: IRAK4
  entrez: '51135'
- word: IRAK1
  symbol: IRAK1
  source: hgnc_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: TMPRSS2
  symbol: TMPRSS2
  source: hgnc_symbol
  hgnc_symbol: TMPRSS2
  entrez: '7113'
- word: Furin
  symbol: FURIN
  source: hgnc_symbol
  hgnc_symbol: FURIN
  entrez: '5045'
- word: ACE2
  symbol: ACE2
  source: hgnc_symbol
  hgnc_symbol: ACE2
  entrez: '59272'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: CTSL-dependent
  symbol: CTSL
  source: hgnc_symbol
  hgnc_symbol: CTSL
  entrez: '1514'
- word: CTSL
  symbol: CTSL
  source: hgnc_symbol
  hgnc_symbol: CTSL
  entrez: '1514'
- word: TLR7
  symbol: TLR7
  source: hgnc_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR3
  symbol: TLR3
  source: hgnc_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: MyD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: IRAK4
  symbol: IRAK4
  source: hgnc_symbol
  hgnc_symbol: IRAK4
  entrez: '51135'
- word: IRAK1
  symbol: IRAK1
  source: hgnc_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: TRAF3
  symbol: TRAF3
  source: hgnc_symbol
  hgnc_symbol: TRAF3
  entrez: '7187'
- word: TBK1
  symbol: TBK1
  source: hgnc_symbol
  hgnc_symbol: TBK1
  entrez: '29110'
- word: TRAF3
  symbol: TRAF3
  source: hgnc_symbol
  hgnc_symbol: TRAF3
  entrez: '7187'
- word: TBK1
  symbol: TBK1
  source: hgnc_symbol
  hgnc_symbol: TBK1
  entrez: '29110'
- word: TRAF3
  symbol: TRAF3
  source: hgnc_symbol
  hgnc_symbol: TRAF3
  entrez: '7187'
- word: ACE2
  symbol: ACE2
  source: hgnc_symbol
  hgnc_symbol: ACE2
  entrez: '59272'
- word: IRF7
  symbol: IRF7
  source: hgnc_symbol
  hgnc_symbol: IRF7
  entrez: '3665'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: IRF7
  symbol: IRF7
  source: hgnc_symbol
  hgnc_symbol: IRF7
  entrez: '3665'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: Nsp3
  symbol: NSP3
  source: hgnc_alias_symbol
  hgnc_symbol: SH2D3C
  entrez: '10044'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: IFN
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: Туре
  symbol: TYPE
  source: hgnc_alias_symbol
  hgnc_symbol: SGCG
  entrez: '6445'
- word: IL-1B
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: +IL-1B
  symbol: IL1B
  source: hgnc_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: HDAC2
  symbol: HDAC2
  source: hgnc_symbol
  hgnc_symbol: HDAC2
  entrez: '3066'
- word: IRF7
  symbol: IRF7
  source: hgnc_symbol
  hgnc_symbol: IRF7
  entrez: '3665'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
chemicals:
- word: CoV-2
  source: MESH
  identifier: C402301
diseases:
- word: SARS-CoV-2
  source: MESH
  identifier: C000657245
figid_alias: PMC8013908__F1
redirect_from: /figures/PMC8013908__F1
figtype: Figure
---
